Endocrine disruptors in the workplace, hair spray, folate supplementation, and risk of hypospadias: Case-control study

Environmental Health Perspectives

Volumn 117, Issue 2, 2009, Pages 303-307

  Ormond, Gillian ^a,b   Nieuwenhuijsen, Mark J ^b,c   Nelson, Paul ^d   Toledano, Mireille B ^b   Iszatt, Nina ^b   Geneletti, Sara ^b   Elliott, Paul ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^d Phrisk Ltd   (United Kingdom)

Author keywords

Endocrine disruptors; Folate supplementation; Hair spray; Hypospadias; Occupation

Indexed keywords

ANTIANDROGEN; ENDOCRINE DISRUPTOR; FOLIC ACID; PHTHALIC ACID;

ADOLESCENT; ADULT; ARTICLE; CASE CONTROL STUDY; CHILD; CLASSIFICATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HYPOSPADIAS; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OCCUPATIONAL EXPOSURE; PATIENT REFERRAL; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SURGEON; TELEPHONE; UNITED KINGDOM; VEGETARIAN DIET; VITAMIN SUPPLEMENTATION; WORKPLACE;

ADOLESCENT; ADULT; BIRTH WEIGHT; CASE-CONTROL STUDIES; CHILD; COSMETICS; DIETARY SUPPLEMENTS; ENDOCRINE DISRUPTORS; ENGLAND; FEMALE; FOLIC ACID; GESTATIONAL AGE; HUMANS; HYPOSPADIAS; INFANT, NEWBORN; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PREGNANCY; SOCIOECONOMIC FACTORS; WORKPLACE; YOUNG ADULT;

EID: 60749091238     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.11933     Document Type: Article

References (43)

1. Adibi JJ, Perera FP, Jedrychowski W, Camann DE, Barr D, Jacek R, et al. 2003. Prenatal exposures to phthalates among women in New York City and Krakow, Poland. Environ Health Perspect 111:1719-1722.
2. Aho MO, Koivisto AM, Tammela TL, Auvinen AP. 2003. Geographical differences in the prevalence of hypospadias in Finland. Environ Res 92:118-123.
3. Akaike H. 1974. A new look at statistical model identification. IEEE Trans Automat Contr AU-19:716-722.
4. Akre O, Boyd HA, Ahlgren M, Wilbrand K, Westergaard T, Hjalgrim H, et al. 2008. Maternal and gestational risk factors for hypospadias. Environ Health Perspect 116:1071-1076.
5. Angerpointner TA. 1984. Hypospadias - genetics, epidemiology and other possible aetiological influence. Z Kinderchir 39:112-118.
6. Baskin LS, Himes K, Colborn T. 2001. Hypospadias and endocrine disruption: is there a connection? Environ Health Perspect 109:1175-1183.
7. Blom HJ, Shaw GM, den Heijer M, Finnell RH. 2006. Neural tube defects and folate: case far from closed. Nat Rev Neurosci 7:724-731.
8. Brouwers MM, Feitz WFJ, Roelofs LAJ, Kiemeney LALM, de Gier RPE, Roeleveld N. 2007. Risk factors for hypospadias. Eur J Pediatr 166:671-678.
9. Carmichael SL, Shaw GM, Laurent C, Lammer EJ, Olney RS. 2005. Hypospadias and maternal exposures to cigarette smoke. Paediatr Perinat Epidemiol 19:406-412.
10. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. 2006. COT Meeting Report on the Development and Function in Adulthood of the Human Male Reproductive System - Potential Chemical-Induced Effects. COT statement, 2006/11. Available: http://cot.food.gov.uk/cotstatements/cotstatementsyrs/cotstatements2006/ 371075 [accessed 24 February 2008].
11. Czeizel AE. 1996. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 62:179-183.
12. Czeizel AE, Rockenbauer M, Sorenson HT, Olsen J. 2001. The teratogenic risk of trimethoprim-sulfonamides: a population based case-control study. Reprod Toxicol 15:637-646.
13. Department of Health. 2000. Report on Health and Social Subjects: 50. Folic Acid and the Prevention of Disease. Report of the Committee on Medical Aspects of Food and Nutrition Policy. London:The Stationery Office.
14. Dolk H, Vrijheid M, Scott JE, Addor MC, Botting B, de Vigan C, et al. 2004. Toward the effective surveillance of hypospadias. Environ Health Perspect 112:398-402.
15. Geneletti S, Richardson S, Best N. 2008. Adjusting for selection bias in retrospective case-control studies. Biostatistics 10(1):17-31.
16. Harris EL. 1990. Genetic epidemiology of hypospadias. Epidemiol Rev 12:29-40.
17. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA. 2000. Folic acid antagonists during pregnancy and the risk of birth defects. New Engl J Med 343:1608-1614.
18. Hubinger JC, Havery DC. 2006. Analysis of consumer cosmetic products for phthalate esters. J Cosmet Sci 57:127-137.
19. Irgens A. 2000. Birth defects and paternal occupational exposure. Hypotheses tested in a record linkage based dataset. Acta Obstet Gynecol Scand 6:465-470.
20. Kallen B. 1988. Case control study of hypospadias, based on registry information. Teratology 38:45-50.
21. Kallen K. 1997. Maternal smoking and urinary organ malformations. Int J Epidemiol 26:571-574.
22. Kallen B, Bertollini R, Castilla E, Czeizel A, Knudsen LB, Martinez-Frias ML, et al. 1986. A joint international study on the epidemiology of hypospadias. Acta Paediatr Scand Suppl 324:1-52.
23. Koo HJ, Lee BM. 2004. Estimated exposure to phthalates in cosmetics and risk assessment. J Toxicol Environ Health 67:1901-1914.
24. Kristensen P, Irgens LM, Anderson A, Bye AS, Sundhein L. 1997. Birth defects among offspring of Norwegian farmers, 1967-1991. Epidemiology 8:537-544.
25. Lottrup G, Andersson A-M, Leffers H, Mortensen GK, Toppari J, Skakkebaek NE, et al. 2006. Possible impact of phthalates on infant reproductive health. Int J Androl 29:172-180.
26. Main KM, Mortensen GK, Kaleva MM, Boisen KA, Damgaard IN, Chellakooty M, et al. 2006. Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect 114:270-276.
27. Mylchreest E, Sar M, Wallace DG, Foster PM. 2002. Fetal testosterone insufficiency and abnormal proliferation of Leydig cells and gonocytes in rats exposed to di(n-butyl) phthalate. Reprod Toxicol 16:19-28.
28. Mylchreest E, Wallace DG, Cattley RC, Foster PM. 2000. Dose-dependent alterations in androgen-regulated male reproductive development in rats exposed to di(n-butyl) phthalate during late gestation. Toxicol Sci 55:143-151.
29. National Diet and Nutrition Survey. 2003. Vol 3. Adults Aged 19 to 64 Years. Vitamin and Mineral Intake and Urinary Analytes. London:The Stationery Office.
30. Nelson P, Nieuwenhuijsen M, Kold Jensen T, Mouriquand P, Hughes I, Wilcox D, et al. 2007. Prevalence of hypospadias in the same geographic region as ascertained by three different registries. Birth Defects Res A Clin Mol Teratol 79:685-687.
31. Neto MR, Castilla EE, Paz JE. 1981. Hypospadias: an epidemiological study in Latin America. Am J Med Genet 10:5-19.
32. North K, Golding J. 2000. A maternal vegetarian diet in pregnancy is associated with hypospadias. The ALSPAC Study Team. Avon Longitudinal Study of Pregnancy and Childhood. BJU Int 85:107-113.
33. Park DK, Gelman A, Bafumi J. 2004. Bayesian multilevel estimation with poststratification: state-level estimates from national polls. Political Anal 12:375-385.
34. Paulozzi LJ. International trends in rates of hypospadias and cryptorchidism. 1999. Environ Health Perspect 107:297-302.
35. Pierik FH, Burdof A, Deddens JA, Juttmann RE, Weber RFA. 2004. Maternal and paternal risk factors for cryptorchidism and hypospadias: a case-control study in newborn boys. Environ Health Perspect 112:1570-1576.
36. R Development Core Team. 2005. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. Available: http://www.R-project.org [accessed 24 February 2008].
37. Sharpe RM, Rivas A, Walker M, McKinnell C, Fisher JS. 2003. Effect of neonatal treatment of rats with potent or weak (environmental) oestrogens, or with a GnRH antagonist, on Leydig cell development and function through puberty into adulthood. Int J Androl 26:26-36.
38. Swan SH, Main KM, Liu F, Stewart SL, Kruse RL, Calafat AM, et al. 2005. Decrease in anogenital distance among male infants with prenatal phthalate exposure. Environ Health Perspect 113:1056-1061.
39. Toppari J, Larsen JC, Christiansen P, Giwercman A, Grandjean P, Guillette LJ Jr, et al. 1996. Male reproductive health and environmental xenoestrogens. Environ Health Perspect 104:741-803.
40. U.S. National Library of Medicine/National Institutes of Health. 2008. Medline Plus Medical Encyclopedia. Available: http://www.nlm.nih.gov/ medlineplus/ency/article/002705.htm [accessed 24 February 2008].
41. Van Tongeren M, Nieuwenhuijsen MJ, Gardiner K, Armstrong B, Vrijheid M, Dolk H, et al. 2002. A job-exposure matrix for potential endocrine-disrupting chemicals developed for a study into the association between maternal occupational exposure and hypospadias. Annal Occup Hyg 46:465-477.
42. Vrijheid M, Armstrong B, Dolk H, van Tongeren M, Botting B. 2003. Risk of hypospadias in relation to maternal occupational exposure to potential endocrine disrupting chemicals. Occup Environ Med 60:543-550.
43. Weidner IS, Moller H, Jensen TK, Skakkebaeb NE. 1998. Cryptorchidism and hypospadias in sons of gardeners and farmers. Environ Health Perspect 106:793-796.